Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Esperion Therapeutics Inc (NASDAQ: ESPR) closed at $1.55 down -1.90% from its previous closing price of $1.58. In other words, the price has decreased by -$1.90 from its previous closing price. On the day, 9.0 million shares were traded.
Ratios:
For a deeper understanding of Esperion Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 19 ’25 when Warren Eric sold 239 shares for $1.87 per share. The transaction valued at 446 led to the insider holds 159,759 shares of the business.
Halladay Benjamin sold 11 shares of ESPR for $20 on Feb 19 ’25. The Chief Financial Officer now owns 240,671 shares after completing the transaction at $1.86 per share. On Feb 19 ’25, another insider, Warren Eric, who serves as the Officer of the company, bought 239 shares for $1.87 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92.
Stock Price History:
Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $1.56. The 50-Day Moving Average of the stock is -20.34%, while the 200-Day Moving Average is calculated to be -27.93%.
Shares Statistics:
A total of 197.85M shares are outstanding, with a floating share count of 195.89M. Insiders hold about 0.99% of the company’s shares, while institutions hold 65.75% stake in the company.
